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Persistent virus infections are characterized by the inability of the host's 
immune  system to  eradicate  the  infectious agent. This may result from a failure 
or dysfunction of  the immune  response or to a viral property which allows the 
infectious agent or infected cell  to escape immunosurveillance. 
For  example, Scrapie,  Kuru, and  Jacob-Creutzfeldt  agents may not  elicit  a detectable 
immune response (1, 2), whereas other viruses  such as mouse thymic agent,  lactic 
dehydrogenase virus,  or measles virus  may alter  the immune response owing to their 
replication  in or destruction  of  lymphoid cells  [thymus-derived (T) and bone marrow- 
derived (B) lymphocytes and/or macrophages] which comprise the immune system (re- 
viewed in references  3 and 4). Lack of or diminished response to viral  antigens may 
perhaps also  occur alter  high antigen loads  or by infection  before  maturation of the 
immune system (5,  6). 
In contrast,  certain  viruses  like  herpes simplex,  cytomegalo, and measles persist 
despite  a competent  and  vigorous  host  immune response.  Here cells  bearing  viral  genetic 
information are not eliminated by immune attack mechanisms. This may occur when 
appropriate  concentrations  of  immune reagents are  not  reached  in  certain  organs,  when 
the  infected  cell  is  not  in  the  appropriate  phase  of  its  growth  cycle  (7,  8),  or  when there  is 
insufficient  expression of  viral  antigens on the cell's  surface  (9, 10).  Specific  anti-viral 
antibodies  can strip  viral  antigens off  the cell's  plasma membrane, leaving a cell  in 
which virus  persists  but which is  resistant  to lysis  by either  viral-specific  lymphocytes 
(11)  or by antibody (A)  I  and complement (C) (9).  In addition,  the virus  itself  may have 
properties which favor its persistence.  This may be by integration  of viral  genetic 
information  in  the  host  genome (12-14),  by  selection  of  less  virulent  variants  or  tempera- 
ture-sensitive  mutants (15),  or by generation of  defective  interfering  (DI)  virus  (16-18). 
Virus-infected  cells  may release  products,  like  interferon,  that play a role  in both  viral 
and immune regulation  (19-21). 
*  This  is  publication  no. 1275  from the Department of  Immunopathology, Scripps  Clinic  and 
Research  Foundation,  La  Jolla,  Calif.  92037.  This  research  was  supported  by  U.S.  Public  Health 
Service  grants  NS-12428,  AI-07007,  AI-09484,  and  AI-12438. 
1 Abbreviations used in this paper: A, antibody; DI, defective  interfering; LCMV, lymphocytic 
choriomeningitis virus; MEM, Eagle's minimal essential medium supplemented with glutamine, 
antibiotics, and serum; MOI, multiplicity of infection; NP40, Nonidet P-40; PFU, plaque forming 
unit(s); S, standard; VSV, vesicular stomatitis virus. 
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Lymphocytic choriomeningitis  virus (LCMV) infection of cultured cells is a convenient 
model in which to study both immune regulation and viral persistence. Parameters of 
immunologic-mediated  injury of virus-infected cells by T lymphocytes (22), anti-viral A 
and C  (23,  24), and antibody-dependent  lymphocyte killing (24) have been described as 
has the natural state of LCMV persistence in vivo (25-28) and in vitro (29-30).  At~r 
infection of cultured  cells  with  LCMV,  infectious or  standard  (S)  virus  is  initially 
generated, followed in time by the production and release of DI virus without detectable S 
virus (29,  31).  Cloning, superinfection, and immunofluorescence analyses indicate that 
most if not all persistently infected cells carry viral genetic information (29). Neither the 
generation of temperature-sensitive mutants  (R.  M.  Welsh,  unpublished data),  the 
integration of viral genome (32, 33), nor the production of interferon (29, 31, 34, 35) has 
been detected in cultures of LCMV persistently infected cells. 
To better understand virus persistence and escape from immune surveillance, 
we  studied  the  susceptibility of LCMV-infected cells  in  both  the  acute  and 
persistent  stages  of infection to  immune  cytolysis  mediated  by  sensitized  T 
lymphocytes and anti-LCM viral A and C. We noted that a significant number of 
persistently infected culture cells escaped killing by both sensitized T  lympho- 
cytes  and  by  anti-viral A  and  C.  The  inability to  lyse  virus-infected cells 
correlated with DI virus inhibition of viral antigen synthesis. The likely impor- 
tance of these findings in in vivo infection are discussed. 
Materials  and  Methods 
Virus, Cells, and Infection.  The Armstrong strain of LCMV (36) was used throughout these 
studies. L-929 cells  (H-2k)  were propagated in Eagle's minimal essential media supplemented 
with glutamine, antibiotics, and 10% fetal calf serum (MEM). Nl15 (murine neuroblastoma clone 
115, H-2a) (37) and BHK 21/13S (36) cells were grown in Dulbocco's media as described.  For acute 
infection, a virus stock containing  4 × 10  ~  plaque-forming  units (PFU)/ml was prepared after three 
dilute passage transfers in L-929 cells to avoid large contamination  with DI LCMV. Stock virus 
was diluted 1:33, and 1 ml was added to each tissue culture Petri plate (Falcon no. 3002; Falcon 
Plastics, Div.  of BioQuest,  Oxnard, Calif.)  containing 1-1.5  ×  10  e L-929 cells  (multiplicity of 
infection (MOI) of approximately 1). After adsorption at 37°C for 11/2-2 h the virus inoculum was 
decanted, and the monolayers on the cultured plates were replenished with 5 ml MEM. Multiple 
identical samples were run in each experiment to ensure that points from different time periods 
represented data derived from separate Petri plates. At designated times, culture fluids and cells 
were harvested and analyzed by the method listed below. Acutely infected cultures were main- 
tained for 7 days before the first passage and passaged weekly thereafter. Persistently infected 
cells were routinely passaged weekly and assayed for viral antigenic expression and infectivity as 
previously reported (29, 37). To initiate  persistent infection, cultures were infected with L-929 cell- 
grown LCMV which had been passaged through a 0.22/xm filter. The L-929, NllS, and BHK 
culture lines persistently  infected with LCMV were maintained  in this laboratory for over 2 yr. 
S LCMV was titrated by the BHK agarose suspension  plaque assay (38) and virus-infected  cells 
were assayed by infective center assay on the same cells (39). The assay for DI LCMV was the 
infective center inhibition  assay (16); briefly, monolayere of L-929 cells were exposed to an inter- 
fering dose of virus for 11/2 h and then challenged with S LCMV. After an additional 11/2 h incuba- 
tion the cells were washed several times and then plated onto the BHK cell plates. Control prep- 
arations received MEM  in place of the  interfering inoculum. The amount of DI LCMV  was 
calculated by the relative inhibition of infective center formation. 
Lymphocyte-Mediated Killing.  Uninfected and LCMV-infected L-929 cells were radiolabeled 
by mixing 5  ×  105 cells with 20  /xCi of 51Cr (New England Nuclear Corp.,  Boston,  Mass.)  in 
minimum volume. After 40 rain incubation at 37°C in 5% CO2, the cells were washed five times 
with 10 ml of MEM and resuspended in MEM to a final concentration of 1 ×  105 cells/ml. The 
labeled cells in 100-gl samples were distributed into individual  microtiter wells (Falcon plate no. 
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from C3H/St (H-2k) or A/J (H-2a) mice were added. Both murine strains are syngeneic with L-929 
ceils in the K region of the H-2 locus (40). Spleens were removed from three to five uninfected mice 
or mice injected 5-7 days previously by the intraperitoneal route with 3 x  104 PFU of LCMV. The 
pooled  spleens  were  gently  squeezed  with  forceps,  liberating the  ceils,  and  aggregates  were 
removed by fltration through cheesecloth. Erythrocytes in the preparation were lysed by treat- 
ment with 0.83% NH4C1 for 5 min. After two washes with MEM, the spleen cells were added to 
51Cr-labeled target ceils at a  constant ratio of 100:1.  Varying amounts of sensitized lymphocytes 
were used by mixing them with lymphocytes obtained from normal mice (100:0,  75:25,  50:50, 25:75 
and 0:100).  Samples of target cells treated with MEM and 1% Nonidet P-40 (NP40) (Shell Chemical 
Co.,  New  York)  served  as  controls for  spontaneous  51Cr release  and  maximum  5~Cr release, 
repectively. Incubations lasted for 16 h at 37°C.  Assay plates were then centrifuged at 600 g  for 5 
min, and 100 ml of supernatant fluid was removed from each well, placed into a  glass tube, and 
counted in a Searle automatic gamma counter (Amersham/Searle Corp., Arlington Heights, Ill.). 
Determinations were run in quintuplicate. The percent specific ~Cr release was calculated by the 
following equation: 
% specific release =  (cpm test sample -  cpm MEM control)  x  100. 
(cpm NP40 control -  cpm MEM control) 
Identification of T  lymphocytes as cells that killed virus-infected targets was determined by 
depletion experiments in which T  cells were  removed from the lymphocyte population by the 
addition of A to theta antigen and C  (24). 
A-Mediated  C-Dependent Killing.  In most experiments fresh sera before or after immuniza- 
tion of guinea pigs with purified LCMV grown in BHK cells (36) served as the source of C or anti- 
viral A  and C, respectively. When necessary, sera were absorbed with L-929 and/or Nl15 unin- 
fected  cells to  remove cross-reacting antibodies against cell membrane  determinants  (23,  41). 
Guinea pig IgG was prepared by ammonium sulfate precipitation and DEAE-cellulose chromatog- 
raphy.  IgG (2 mg/ml) that was pure as determined by Ouchterlony and immunoelectrophoresis 
analysis was conjugated to fluorescein isothiocyanate or radiolabeled with 125I by the chloramine-T 
method  (41).  Congenic antibodies to H-2k  and to H-2d  were a  gift from Dr.  Rolf Zinkernagel, 
Scripps Clinic and Research Foundation, La Jolla, Calif. 
The ability of anti-LCM viral antibody in the presence or absence of C to kill virus-infected or 
uninfected ceils was assayed by the microcytotoxicity method (42).  Briefly, 6 ~1 of fresh antiserum 
(A and C source) and 1/~1 of cell suspension (5 x  10~/ml in MEM) were discharged under mineral 
oil onto a  Moiler-Coates plate (HTI Corp.,  Associated Biomedic Systems, Buffalo,  N.  Y.).  In all 
experiments a control consisting of cells and heated serum (56°C,  30 rain) was included. The plates 
were then incubated for 90 min at 37°C after which 1 ftl of 5% eosin and then 1 ~1 of undiluted 
formaldehyde were added to each reaction mixture. Viability was assessed by using a  binocular 
inverted phase microscope with an adjustable condensor (6-ram focal point) at a  magnification of 
200.  When different sources of A  and C  were employed, the cells were incubated with 2  /~1 of A 
solution (previously heated at 56°C for 30 rain) for 30 rain at 37°C after which 6/A of C was added. 
For  each  experimental  point  200  cells  were  counted.  Nonspecific  background  of cells  never 
exceeded 5%. 
Detection of  C Receptors.  C3b receptors were detected with antibody-coated sheep erythrocytes 
treated with rabbit serum deficient in the 6th component of C  (EAC1423b cells).  C3d receptors 
were detected with antibody-covered sheep erythrocytes treated with mouse serum deficient in the 
5th C component (EAC1423d cells). The exact procedures for making these indicator cells, use of 
negative and positive controls, and detection of C3b and C3d receptors on cells have been detailed 
elsewhere (43,  44). 
Immunofluorescence Assay.  L-929 cells grown on cover slips in Petri dishes were infected with 
LCMV  as described above.  At designated time intervals the cells were fixed  in ether alcohol, 
washed in 95% alcohol (28),  and stained directly with monospecific guinea pig IgG conjugated to 
fluorescein isothiocyanate. After vigorous pipetting, the remaining cells in the Petri dish were 
suspended in phosphate-buffered saline, and a  pellet of 5  x  105 living unfixed cells was stained 
with the same A conjugate (23). The percent of ceils expressing viral antigens was calculated after 
counting 100-200 cells. 
Quantitation of  Surface Viral Antigens.  The numbers of specific antibody molecules binding to 
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brief, guinea pig IgG containing A to LCMV was labeled with 1~5I while guinea pig IgG lacking A 
to LCMV was labeled with 13q. Both preparations were absorbed against uninfected L-929 coils and 
deaggregated by ultracentrifugation before use. Varying concentrations of  uninfected and infected 
L-929 cells (1 x  10', 5 × 104, 1 ×  105, and 5 ×  105) were mixed with beth '"I- and 13q-labeled IgG 
preparations. In other assays increasing amounts of radiolabeled IgG were added to constant 
numbers of cells. By examining the saturation curves, an approximation of a maximal amount of 
antibody molecules binding per cell at antigen saturation levels was calculated (41). 
DI LCMV Analysis and Assay.  DI  LCMV  (assayed by infective center  inhibition assay) 
without detectable S virus was isolated from culture fluids of persistently infected L-929, BHK, or 
Nl15 cultures. The density of L-929 cell-grown DI LCMV purified by methanol precipitation and a 
discontinuous sucrose gradient (36) was determined by sedimentation on an 11 ml 20-50% wt/wt 
continuous suCrose gradient centrifuged at 40,000 rpm for 16 h  in a  Beckman no.  SW41 rotor 
(Beckman Instruments, iiInc., Fullerten, Calif.). Individual samples were collected, and the densi- 
ties were recorded using a refractemeter. Each sample was then diluted :1:3 in growth M]~VI and 
1.5-ml samples were added to L-929 monolayers to test for the presence of interfering material by 
infective center inhibition assay. Controls containing MEM and similar sucrose concentrations 
were also used as an interfering inoculum. The residual sucrose in each sample (17% sucrose 
highest in concentration) did not inhibit infective center formation. S LCMV was sedimented in a 
separate gradient in parallel, and fractions were collected and assayed for plaque formation. 
Cultivation and Immunofluorescent Staining of Mouse Peritoneal Cells.  Peritoneal cells were 
isolated from control and LCMV persistently infected BALB/c heterologous nude and SWR/J mice. 
These mice had been infected less than 24 h after birth by intracranial inoculation with 700 PFU of 
LCMV and had shed virus throughout their lives. Cells were obtained by washing the peritoneal 
cavity with  6  ml  MEM  lacking serum  but  containing  20  U/ml  heparin  (Lipo-Hepin; Riker 
Laboratories, Inc., Northridge, Calif.). In some instances mice were injected intraperiteneally 
with 1 ml of 10% thioglycollate broth (45) to recruit macrophages to the peritoneal cavity. Cells 
were directly placed on Petri dishes with glass cover slips, and after 1-2 h, the nonadherent cells 
were washed away with MEM.  For immunofluorescent staining of LCMV antigens on the cell 
surface of the adherent cells, several modifications were made. The cells were suspended after 
incubation with 0.3% lidocaine HC1 (Xylocaine; Astra Pharmaceutical Products, Inc., Worcester, 
Mass.) in MEM for 10 min. The suspended cells were stained with fluorescein-conjugated Fab 
fragments of the guinea pig anti-LCMV IgG molecule. Preparation of Fab from guinea pig IgG was 
by papain digestion and DEAE-cellulose chromatography procedure as described (46, 47). The 
method for staining the cytoplasms of adherent peritoneal cells was identical to that for the L-929 
cells. 
Results 
Susceptibility  of Acutely and Persistently Infected L-929 and Nl15  Cells  to 
Immune Attack.  After acute infection ofL-929 cells with LCMV, the amount  of 
infectious virus in the culture fluids peaked on the 2nd through  5th days (Table 
I). De novo  S  LCMV  synthesis observed by changing  the medium  daily in the 
cultures was maximum  at the 2nd and 3rd days. The number  of cells producing S 
virus,  as shown  by infective  center  assay,  correlated  with  the  de  novo  virus 
synthesis. Precipitous drops in the percent infective centers occurred from day 3 
(79%) to day 4 (14%) to day 5 (3%), even though S  LCMV was still present in the 
culture  fluid.  Thereafter,  the  infectivity  declined,  only  to  rise  and  fall  on 
subsequent  passages at days 13, 21, and 29 postinfection. In previously reported 
studies,  marked  peaks  and  valleys  in  S  virus  synthesis  occurred  in  similar 
cultures for up to 100 cell generations  (29, 30). Persistently infected L929, Nl15, 
and  BHK  cells  (infected for over 2 yr) released no detectable  S  virus into the 
culure fluid, and did not form infective centers when plated on uninfected cells 
(Table I). As judged by infective center assay, all persistently infected cells were 
resistant  to  LCMV  superinfection,  indicating  viral  information  in  every  cell 
(29). RAYMOND  M.  WELSH  AND  MICHAEL  B. A. OLDSTONE  1453 
TABLE I 
Kinetics of  Antigenic Expression and Susceptibility ofL-929 Cells Infected with LCMV 
to Immune-Specific Lysis 
% Cells  with vi-  % Immune-specific lysis  PFU/mI* 
PFU  % Infec-  rus antigens$  by:  Day of  in-  with me- 
fection  per ml  dium  tive  cen- 
(log  10)  Change  ters  Cyto-  Surface  A  + C  Lympho- 
plasm  cytes 
1  5.5  5.9  48  5  4  <5§  31 _+ 0.1~1 
2  7.4  8.0  107  60  43  7  58 -+ 0.91 
3  8.3  7.5  79  98  85  27  67  _+ 0.84 
4  8.0  6.7  14  94  74  28  74  -+  1.7 
5  7.9  5.7  3  88  30  5¶  59 -+ 1.2 
6  6.9  4.7  ND**  74  22  -¶  63 _+ 0.45 
7  6.4  3.8  ND  75  12  -¶  54 _+ 1.2 
13  1.0  ND  ND  ND  10  ND  42  ___ 0.65 
21  6.6  ND  ND  26  12  ND  38 _+ 1.5 
29  3.7  ND  ND  9  3  ND  17 ___ 0.23 
>720  <1.0  <1  <0.001  63  6  <5  46 +_ 0.72 
Uninfected  <1.0  <1  <0.001  <0.01  <0.01  <5  11 _+ 0.53 
* Medium changed daily and fresh medium added in order to determine de novo infectious virus 
synthesis and release. 
$ Determined  by direct  immunofluorescence using  monospecific guinea  pig IgG antibody  to 
LCMV conjugated to fluorescein isothiocyanate. Over 200 cells counted per point. 
§ % of cells killed determined by a microcytotoxicity assay. Number represents the mean value of 
over 200 cells counted. 
H  51Cr specifically released. Number represents  the mean value from quintuplicate  determina- 
tions _+ 1 standard error of  the mean. Effector spleen cells were harvested from syngeneic donor 
mice, C3H/St (H-2k) 6 days after primary challenge with LCMV. Ratio of effector to target cells 
was 100:1. See Materials  and Methods. 
Number represents A-dependent C killing only, but A-independent C killing also occurred in 
these samples. 
** ND, not determined. 
The  susceptibility  of infected  L-929 or Nl15 cells  to immune  attack  during 
different stages of infection was examined by using the 51Cr-release assay for 
lysis by immune lymphocytes and the microcytotoxicity assay for lysis by anti- 
body to  LCMV  and  C.  Spleen  cells  from  C3H/St  or  A/J  mice  (sensitized  to 
LCMV)  killed  significant  numbers  of both  acutely  and  persistently  infected 
L-929 (Table I) or Nl15 (Table II) cells, respectively. In all five experiments per- 
formed using a variety of effector to target cell ratios and spleen cells harvested 
at  varying times  after  sensitization,  significantly fewer  persistently  infected 
cells were killed than acutely infected cells (Tables I and II). The average of five 
experiments indicated that >40% of the persistently infected cells escaped lysis 
by immunologically specific lymphocytes under those conditions. This relative 
inability  of sensitized  spleen  cells  to  kill  persistently  infected  cells  carrying 
LCMV antigens occurred whether the targets were L-929 or Nl15 cells. Lysis of 
acutely and persistently infected target cells was mediated by T  lymphocytes, 
since this killing was abrogated when sensitized spleen cells were treated with 
antibody to theta antigen and C. 
Only acutely infected cells were killed by anti-LCMV viral A  and C. Neither 
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TABLE  II 
Susceptibility  ofNl15 Cells Infected with LCMV to Lysis by Virus-Specific  Cytotoxic T 
Cells 
Exp. 
Percent 5'Cr release from target cells$  Day of  Ratio effec-  spleen 
cells har-  tor to target  Acute LCMV  Persistent 
cell  Uninfected  LCMV infec-  vested*  infection 
tion 
5  100:1  28 ± 0.25  44 ± 0.34  29 +_ 0.21 
6  100:1  18 _+ 0.52  95 _+ 2.4  51 _  1.9 
7  100:1  16 ± 0.47  87 ± 0.76  59 _+ 0.75 
100:1  15 __ 0.37  68 _+ 2.0  44 ±  1.3 
75:1  14 _+ 0.19  58 _+  1.0  35 ±  1.4 
50:1  10 _+ 0.38  53 _+ 0.70  38 _  0.15 
25:1  8 _+ 0.58  51 _  0.39  28 _+ 1.2 
3  7  100:1  17 ± 0.34  75 ±  1.6  61 ± 0.67 
75:1  12 ± 0.40  72 ± 0.52  56 _+ 0.60 
50:1  8.0 _+ 0.042  76 ± 0.98  53 _+ 0.59 
25:1  4.6 ± 0.052  65 _+  1.4  46 _+ 0.30 
10:1  1.5 ± 0.013  34 ± 0.40  32 ± 0.55 
5:1  0.4 _  .0086  21 ± 0.24  17 _+ 0.37 
* Syngeneic A/J mice were infected intraperitoneally  with 2 × 10  ~  PFU of Me70 strain LCMV 5, 6, 
or 7 days before assay. 
For acute infection, Nl15 cells were infected with MOI of 1 and used on the 2nd day after 
infection. Persistently infected cells had been infected with LCMV for over 720 days at the time 
of the assay. Numbers represent the mean of quintuplicate  determinations ± the standard error 
of the mean. 
infected  cells  could  be  lysed  by  anti-viral A  and  C.  Maximal  lysis  usually 
occurred  on  the  2nd  to  4th  day  after  acute  infection  (Table  III).  In  several 
experiments the maximum  amount of specific A-mediated C  lysis was 20-35%. 
In addition, in five of five experiments we  found that  rarely on the  2nd but 
usually by the 3rd to 6th day after infection, a  C  source devoid of antibodies to 
LCMV lysed virus-infected cells (Table III). This C lysis independent of antibody 
to LCMV occurred with guinea pig, rabbit, and human  C  sources. By the 7th to 
8th day after infection and thereafter lysis by C  alone did not occur. This lysis 
was  not associated with the  appearance of C3  receptors  on the  virus-infected 
cells since EAC1423b or EAC1423d indicator cells did not bind to the  LCMV- 
infected L-929  cells.  Further,  this  possibly was  not related to  the  binding of 
nonspecific A(s) to uncovered determinants on the infected cell's membrane  as 
131I control antibodies did not bind to these  cells (Table IV).  Whereas persist- 
ently infected cells were not lysed by anti-LCMV A  and C,  they were readily 
killed by specific A  to their major histocompatibility determinant and C  (Table 
III). Using the same C source, similar numbers of target cells and twofold serial 
dilutions of A to H-2k, we found that the 50% A lysis titers of uninfected, acutely 
infected (day 2),  and persistently infected L-929 cells were 1:26,  1:23, and 1:40, 
respectively. These results indicated that (a) persistently infected cells could be 
lysed by  A  and  C  and  (b)  that  the  amounts  of H-2k  present  on  surfaces  of RAYMOND  M.  WELSH  AND  MICHAEL  B.  A.  OLDSTONE  1455 
TABLE  III 
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1  13  14  13  98  1  0 
2  11  3  16  100  <1  0 
15  22  14  98  2  <1 
25  58  22  100  0  0 
49  68  46  100  3  3 
54  58  ND  ND  0  0 
86  84  ND  ND  2  0 
1  16  11  15  99  0  0 
2  13  10  13  100  0  0 
* Microcytotoxicity  assay  was  described  in  Materials and  Methods.  A alone  killed  <15% of  cells.  C, 
complement source plus MEM.  These are representative  results  of  one of  three experiments. 
Control  ofA toH-2d  did  not  lyse  L-929 (H-2k)  cells.  Rosetting  and  anti-viral  A experiments  were 
run concurrently.  In  all  experiments  L-929 cells  were infected  acutely  with  stock  LCMV  at  MOI 
of  1. 
* Raji  cell  (with C3b and C3d receptors)  control  run concurrently showed >75% binding EAC3b 
and >60% binding  EAC3d indicator  cells  (43,  44). 
uninfected, acutely infected, and persistently infected cells did not vary signifi- 
cantly. 
To  determine  the  relationship  between viral  antigenic  expression  and  the 
susceptibility of virus-infected cells to immune cytolysis, cells were examined 
for their abilities to bind fluorescein-labeled and radiolabeled A to LCMV. The 
binding of anti-viral A labeled with fluorescein (Table I) or ~5I (Table IV) to the 
cell  membrane  peaked  on the  3rd  and  4th  day postinfection.  Thereafter,  the 
amount of viral antigenic expression on the membrane precipitously declined, 
even though  significant  quantities  of S LCMV remained  in the  culture fluid 
(Table I). By 7 days postinfection, the amount of ~25I-A binding to infected cells 
was  the  same  as  that  for uninfected  controls.  In  contrast,  most  cells  in  the 
culture continued to express cytoplasmic viral antigens (Table I). Although 63% 
of the persistently infected cells displayed cytoplasmic viral antigens by fluores- 
cence, there was little antigenic expression on their plasma membranes.  Only 
trace amounts of LCMV antigens appeared on the surfaces of 6% of the persist- 
ently infected cells by fluorescent-binding assay, and these cells were indistin- 
guishable from uninfected controls when the radiolabeled A-binding assay was 
used  (Table IV).  Knowing the  specific activity of the  ~2~I-labeled antibody to 
LCMV,  we  calculated  that  for  A-mediated  C  lysis  to  occur,  the  binding  of 
approximately 5  ×  l0  b A molecules per target cell was required. 
Characteristics  of LCMV Released by Persistently Infected L-929 Cells.  As 
observed with other cell types including Nll5 and BHK (29,  31,  32,  37),  L-929 1456  ANTIGENIC  REGULATION  BY  DEFECTIVE  INTERFERING  VIRUS 
TABLE  IV 
Binding of LCMV Antibodies  to Surfaces ofL-929 Cells Infected with LCMV 
131I (non-LCMV A)  1~sI  (LCMV A)  No. specific  No. cells*  in 
Cell  conditions  A molecules 
assay  CNTS$  % Bind  CNTS$  % Bind  bound 
Acute infection 
Day 1  5 x  105  2,187  0.06  3,710  0.06  1 x  105§ 
5 ×  105  1,928  0.06  2,829  0.05 
Day 2  5 x  105  1,330  0.04  5,389  0.10  2 x  105 
5 ×  104  1,474  0.05  3,570  0.06 
Day 3  5 x  105  1,762  0.05  16,269  0.30  5 ×  105 
5 x  104  1,607  0.05  4,528  0.08 
Day 4  5 ×  105  1,595  0.05  22,847  0.40  7 ×  l0  s 
5 ×  104  1,763  0.05  5,625  0.10 
Day 5  5 x  105  1,815  0.06  9,493  0.16  3 ×  105 
5 x  104  1,527  0.05  3,769  0.06 
Day 6  5 x  105  1,412  0.04  5,879  0.10  2 ×  l0  s 
5 ×  104  1,525  0.05  3,323  0.06 
Day 7  5 x  105  1,502  0.05  6,169  0.11  2 ×  105 
5 ×  104  1,720  0.05  3,402  0.06 
Persistent infection  5 x  105  1,414  0.05  3,726  0.06  1 ×  105§ 
5 ×  104  1,481  0.05  3,425  0.06 
Uninfected  5 x  105  2,063  0.06  3,013  0.05  1 x  105§ 
5 x  105  2,154  0.07  3,555  0.06 
* Cells used in assays were at dilutions of 5 x  105, 1 x  105, and 5 x  104 with results shown for two 
concentrations. 
Radioactive counts (CNTS) corrected for background and crossover. 
§ Background binding levels. 
cells persistently infected with LCMV  were completely resistant  to superinfec- 
tion  with  S  LCMV  but  were  totally  permissive  to  vesicular  stomatitis  virus 
(VSV)  infection  as judged  by  release  of infectious  virus.  These  persistently 
infected cells released virions that by electron microscopy were morphologically 
similar to S  LCMV  (P.  Lampert,  personal  communication).  The  cells released 
an  interfering  component  which  prevented  S  LCMV  synthesis  and  infective 
center formation, and this interfering activity was specifically blocked by anti- 
bodies to LCMV.  Under  the  same  conditions of sedimentation  in sucrose,  the 
density of the interfering activity (DI LCMV) was 1.15-1.165 g/cm  3 as compared 
to  1.165-1.175  g/cm  3  for  S  LCMV.  The  interfering  component  obtained  from 
supernates  of persistently infected BHK  and Nli5  cells also had lower densities 
(1.15-1.165 g/cm  3) than S LCMV. The culture fluids from persistently infected L- 
929,  Nl15,  and BHK  cells produced no detectable LCMV  antigens  when  inocu- 
lated onto susceptible cells, nor did those inoculated cells release a  detectable 
interfering component.  The resistance of these treated  cell cultures to superin- 
fection  by  LCMV  waned  after  24 h.  These  experiments  indicated  that  the 
persistently infected cells released a  DI virus. 
Inhibition  of S  LCMV Antigen  and PFU Synthesis  by DI LCMV.  Cells 
exposed  to  DI  LCMV  isolated  from  either  L-929,  Nl15,  or  BHK  persistently 
infected cultures expressed no viral antigens  by immunofluorescence  at 24 and RAYMOND  M.  WELSH  AND  MICHAEL  B.  A.  OLDSTONE  1457 
TABLE  V 
(A) Prevention of Viral PFU and Antigen Production by DI LCMV and (B) inhibition of 




DI virus  S  cytoplas- Log10  PFU per 
dilution  LCMV  culture  mic anti- 
gens 
Neat DI  +  1.9  3.2 (A) 
1:2 DI  +  3.8  4.3 (B) 
1:4 DI  +  8.4  5.0 (C) 
1:8 DI  +  19.0  5.3 (D) 
1:16 DI  +  19.4  5.8 (E) 
1:32 DI  +  27.1  6.1 (F) 
MEM  +  35.6  6.2 (G) 
MEM only  -  0  <1  (H) 
Exp. B$ 
Interfering  in- 
oculum 
Loglo 
Loglo  PFU 
PFU  yield 
yield  with 
without  LCM  chal-  chal- 
lenge  lenge 
A  2.3  4.8 
B  2.3  4.8 
C  3.0  3.4 
D  3.3  3.7 
E  3.7  4.7 
F  4.0  4.6 
G  4.2  4.4 
H (control)  <1  4.6 
* L-929 cells were exposed to dilutions of a DI LCMV stock prepared from a 120 times concentra- 
tion of medium from persistently infected L-929 cells. After 2 h, S LCMV (MOI = 1) was added to 
the cultures.  After 2 h the inocula were decanted, and MEM was placed on the cells. At 16 h 
postinfection, the  medium  was titrated  for PFU  and the cells were fixed and  stained  with 
immunofluorescent antibody to LCMV. 
Culture  fluid samples  representing  the  16-h harvests  from Table  V A (samples A-H) were 
exposed to L-929 cells for 2 h. The interfering  inocula were decanted, and S LCMV was added to 
the cells at a multiplicity  of 2 PFU per cell. After 2 h the inoculum was removed and medium 
replenished. The culture fluids were harvested  24 h later and titrated for infectivity. 
48 h  after infection. In contrast, cells exposed to S LCMV displayed both cyto- 
plasmic and cell surface viral antigens. When cells were first incubated with DI 
LCMV from either of the above cultures and then challenged with S LCMV, the 
synthesis  of viral  antigens  was  markedly  inhibited.  The  inhibition  of viral 
cytoplasmic antigen synthesis was dose dependent and increased with increas- 
ing  concentrations  of DI  LCMV  (Table  V A).  Table  V A  demonstrates  that 
increasing doses of DI LCMV isolated from L-929 cells reduced the number of 
cells expressing antigens in a  linear manner and lowered the PFU yield loga- 
rithmically. Under conditions of DI virus treatment that reduced the number of 
fluorescent cells by a factor of 20, the number of PFU produced was reduced by a 
factor of 1,000.  In addition to indicating that DI virus at high concentrations 
blocks viral antigen synthesis, this experiment also suggests that much of the 
antigen  present  in  the  DI  virus-treated  cells  is  not  released  in  the  form  of 
infectious S LCMV. Thus, either the antigen is released in a  defective viral or 
protein form, or else the antigen is not released from the cell at all. To determine 
whether the DI plus S virus-treated cells synthesized and released an interfering 
component,  L-929  cells  were  exposed  to  the  culture  fluid  harvests  from  the 
experiment  in  Table  V A  and  then  challenged  with  S LCMV at  a  MOI of 1. 
Samples  C  and  D,  derived  from  a  harvest  of cells  treated  with  1:4  and  1:8 
dilutions of DI virus, significantly inhibited the synthesis of challenge S  LCMV 
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TABLE VI 
Defective Interfering Virus Regulates Expression of LCMV on Cell's Plasma Membrane 
Treatment of L-929 cells  Assay at 24 h  for: 
Infectivity  % Cells with  % 51Cr released on 
First  Second  (loglo PFU/  surface viral  addition of sensi- 
ml)  antigens  tized lymphocytes 
MEM  MEM  0  0  7 _+  0.18 
DI LCMV*  MEM  0  0  7 _+  0.050 
MEM  S LCMV  7.5  33  66  _+  0.15 
DI LCMV  S LCMV  5.1  0  10  _  0.55 
* Supernatant fluids were obtained from BHK cells persistently infected with LCMV and concen- 
trated  120 times (DI  LCMV).  Cells were exposed to DI LCMV (or  MEM) for  11/2 h  and then 
challenged with MEM or S  LCMV (MOI  =  1) for  11/2 h.  Surface antigens were measured by 
immunofluorescence. 
and B) and less DI virus (E and F) did not interfere with S LCMV synthesis. 
This  indicates  that  under  conditions  of infection  with  both  S  plus  DI  virion 
types, S LCMV but little interfering component is produced by 24 h when small 
amounts of DI virus are used (E and F); at higher DI virus concentrations there 
is  a  reduction  in  the  synthesis  of S LCMV but  an  interfering  component  is 
produced (C and  D);  at the highest concentrations of DI LCMV there is little 
production of either S LCMV or an interfering component (A and B). 
DI  LCMV  also  blocked  the  expression  of cell  surface  viral  antigens.  As 
detected by immunofluorescence  24 h  after acute infection,  33%  of L-929 cells 
exposed to S LCMV expressed surface viral antigens,  but no cells treated first 
with DI LCMV did so (Table VI). The yield of S LCMV was reduced by over two 
logs by the DI LCMV in this experiment, and the treated cells were resistant to 
sensitized spleen cell-mediated cytotoxicity (Table VI). These same spleen cells 
readily lysed targets infected with S LCMV only. Again, the inhibition of viral 
antigen synthesis by DI virus depended on the concentration of DI virus in the 
inoculum, as some DI virus preparations which reduced the yield of S LCMV by 
over one log did not render cells resistant to spleen cell killing.  Once initiated, 
viral  antigen  synthesis,  particularly  detectable  at  the  cell  surface,  could be 
arrested by DI virus treatment.  L-929 cells were infected with S LCMV at a 
multiplicity of 5 PFU per cell, and allowed to incubate for 4 h. They were then 
treated  with  different  concentrations  of DI LCMV  isolated  from  persistently 
infected L-929 cells. At 24 h postinfection the cells were examined by immuno- 
fluorescence  for  cytoplasmic  and  cell  surface  viral  antigens.  The  DI  virus 
treatment did not substantially reduce the number of cells expressing cytoplas- 
mic viral antigens  (S LCMV, 66%; S plus DI LCMV, 55%),  although the inten- 
sity  of the  fluorescent  stain  was  clearly  diminished  in  the  DI  virus-treated 
samples.  The number of cells expressing the characteristic  bright fluorescent 
pattern  for  LCMV  was  greatly  diminished  in  DI  virus-treated  samples  (S 
LCMV, 12%; S plus DI LCMV, 2%); some of the S plus DI LCMV-treated cells 
had very light speckles of immunofluorescence, but even when these were taken 
into account, the frequency of cells with surface staining was still lower than in 
the S LCMV-infected cultures (15% vs. 8.8%).  Hence, DI LCMV was capable of 
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TABLE  VII 
Accumulation of Interfering  Component (DI Virus) During Acute LCMV Infection in L- 
929 Cells* 
Day after 
PFU per ml 
initiating 
infection  (log 10) 
% Infective centers*  24-h yield loglo PFU/ml 
Undiluted  Diluted I/i0  Undiluted  Diluted 1/10 
2  7.4  26.0  7.0  6.8  6.6 
3  8.3  12.0  15.0  5.8  6.7 
4  8.0  7.3  14.0  5.7  6.6 
5  7.9  4.4  15.0  5.7  6.6 
7  6.4  1.1  ND§  5.9  ND 
21  6.6  37.0  ND  6.6  ND 
* Cell monolayers were infected with LCMV (MOI = 1) and the culture fluid was sampled daily 
and titrated for PFU.  The collected culture fluids were then inoculated onto L-929 cells.  1 h 
postinfection these cells were assayed for infective center formation. The remaining cells were 
reseeded onto Petri dishes and incubated for 24 h under MEM, after which the culture fluids 
were titrated. 
$ Culture fluids used undiluted or diluted 10-fold for assay system. 
§ ND, not determined. 
associated  with  the  inability  of immune  reagents  to lyse virus-infected cells 
(Table V  and VI). 
Production of an Interfering Component During Acute LCMV Infection.  To 
determine whether the viral antigen shutdown during acute infection in vitro 
might  be  associated  with  production  of DI  LCMV  and  its  interference  with 
LCMV  antigenic  expression,  culture  fluids  after  the  2nd  day  of the  acute 
infection were  collected and  studied.  Such  fluids  obtained  on  days  3-7  after 
infection formed infective centers poorly when compared to samples obtained 21 
days after acute infection (Table VII). Similarly, relatively few PFU formed in 
the culture fluid of L-929 cells inoculated with these same samples.  Dilution of 
samples from days 3, 4, and 5, but not day 2, before inoculation onto L-929 cells 
enhanced infective center formation and increased the 24-h yield 10-fold. When 
the day 4 and day 2 harvests were mixed and inoculated onto L-929 cells, there 
consistently were 50-80% fewer infective centers formed than with cells treated 
with day 2 preparations only. The interference was not medium dependent, as 
the interfering component could be pelleted at 105,000 g  for 60 min in an ultra- 
centrifuge and resuspended in fresh MEM. These experiments indicate that an 
interfering component was present in the virus stock harvested on days 3-7 after 
infection. 
To determine whether the interfering component was made de novo or was a 
stable  by-product  of acute  viral  infection  which  accumulated  in  the  media 
associated  with  a  relatively  fast  inactivation  of S  LCMV,  culture  fluids  of 
infected  cells  were  changed  daily,  and  analyzed  for  their  abilities  to  block 
infective center formation. Under these conditions the activity of the interfering 
substance was again observed on the 3rd and 4th day after instituting an acute 
infection. De novo synthesis of an interfering component on days 5 and 6 post- 
infection was not detected (without concentration), likely reflecting the culture's 
shutdown in surface antigen production. In parallel, culture fluids obtained from 
the day 4 harvest, undiluted or diluted 10-fold, were added to L-929 cell monolay- 
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TABLZ VIII 
Immunofluorescent  Staining of Peritoneal Cells from LCMV- 
Carrier Mice 
Mice  % Positive  cells 
Strain  No.  Cytoplasm  Surface 
nu/+ (BALB/c) 
SWR/J 
1  73  7.6 
2  71  22 
3  22  17 
1  35  16 
2  85  50 
3  65  21 
Adherent peritoneal cells from 8- to 14-mo-old mice were stained with fluoresceinated 
IgG (cytoplasm) or IgG Fab (surface) containing antibody to LCMV. 
lum produced at least as many and sometimes twice the number of fluorescing 
cells as the undiluted inoculum (e.g. undiluted inoculum, 15% fluorescent cells; 
10-fold diluted inoculum, 25% fluorescent cells), indicating that the interfering 
component in the  culture fluid blocked antigen  synthesis by the S virus also 
present in the culture fluid. 
Antigenic Expression  on  Cells from Persistently Infected  Mice.  Adherent 
peritoneal cells isolated from LCMV persistently infected SWR/J or nu] +  (on a 
BALB/c background)  mice resembled persistently infected cells in culture.  As 
judged by immunofluorescence  significantly  more cells expressed cytoplasmic 
antigens than  surface viral  antigens  (Table VIII).  The relative frequencies of 
cells with viral antigens varied markedly between individual mice. Peritoneal 
cells isolated from persistently infected mice released low numbers of PFU into 
the culture fluid. Very few (0.1%)  of those cells scored as infective centers, and 
the cells were refractory to superinfection by S LCMV (Table IX). Addition of 
S LCMV  to  a  culture  of peritoneal  cells  from  LCMV-carrier  mice  did  not 
increase the number of fluorescent cells in the culture.  In contrast,  peritoneal 
cells harvested from uninfected mice and inoculated with S LCMV release PFU 
into the culture fluid, scored high as infective centers (20%) and produced viral 
antigens.  Although  searched for, only sporadically was an interfering  compo- 
nent against LCMV synthesis found in the culture fluid of peritoneal cells from 
LCMV-carrier  mice.  Owing to the  low yields of the interfering  component,  it 
was not characterized when found. 
DI  LCMV produced  in  persistently  infected  BHK cells  can  interfere  with 
S LCMV synthesis in adherent peritoneal cells. Table X shows that the infective 
center  number  of peritoneal  cells  infected  with  S LCMV  was  significantly 
reduced by pretreatment  with DI LCMV. 
Discussion 
The concentration of LCMV antigens  on the surface of infected cells is high 
during the early stages of infection but is significantly reduced as the infection 
continues. This dampening or modulation of antigenic expression is a function of 
the virus infection per se and occurs in the absence of added antibody. After the RAYMOND  M.  WELSH  AND  MICHAEL  B.  A.  OLDSTONE  1461 
TABLE  IX 
Inhibition  of LCMV Synthesis in Mouse Peritoneal Cells 
Superinfec-  % Fluores-  % Infective  Loglo/ml PFU 
Source of  cells  tion  with S  cent cells  centers  yield 
LCMV  (cytoplasm) 
Uninfected mouse  No  0  ND*  ND 
Uninfected mouse  Yes  51  20.0  4.3 
LCMV-carrier mouse  No  56  0.1  2.0 
LCMV-carrier mouse  Yes  41  0.3  3.5 
Adherent peritoneal  cells  from SWR/J normal or  LCMV-carrier  mice were superinfected  with  S 
LCMV  (at  a multiplicity  of  5 PFU per  cell)  and incubated for  48  h. Cells  were  then  stained  with 
immunofluorescent antiserum to LCMV  and then titrated  for  infective  centers  and release  of 
PFU into  the culture  fluid. 
* ND, not  done. 
TABLE  X 
DI LCMV Inhibits S  LCMV Synthesis in Mouse Peritoneal Cells 
Log,o/ml 
Cell  Interfering  inocu-  % Infective  PFU yield 
lum  Challenge virus  centers  (24  h postin- 
fection) 
Peritoneal  MEM  S  LCMV  0.77  3.3 
Peritoneal  DI LCMV  S  LCMV  0.15  2.5 
L-929  MEM  S  LCMV  3.0  3.7 
L-929  DI LCMV  S  LCMV  0.05  1.8 
Peritoneal  cells  from normal SWR/J mice and L-929 cells  were exposed  to  DI LCMV  concentrated 
120 times from the culture fuid of  persistently  infected  BHK  cells.  Cells  were then challenged 
with S LCMV  at  a multiplicity  of  0.3  PFU per  cell.  Infective  centers  were measured immediately 
after  S LCMV  adsorption,  and PFU were titrated  24 h after  incubation. 
infection of L-929  cells with LCMV at a  MOI of 1,  the amount of LCMV cell 
surface antigens peaked on the 2nd to 4th day and then dropped precipitously, 
and cells persistently infected with LCMV for over 2 yr displayed low quantities 
of viral  antigens  on  their  plasma  membrane surfaces.  In  contrast to  these 
differences in expression of surface viral antigens, the majority of cells during 
both  acute  and  persistent  infections had  detectable  viral  antigens  in  their 
cytoplasms. These antigenic characteristics of persistently infected cells have 
been observed previously (32, 48). 
The susceptibility of LCMV-infected cells to immune lysis by anti-LCMV A 
and C directly paralleled the presence and concentration of LCMV antigens on 
the  surface of the  infected cells.  On  the  2nd  to  4th  day postinfection,  viral 
antigenic expression was maximal and A-mediated C-dependent lysis occurred. 
Persistently infected cells, which had little cell surface viral antigenic expres- 
sion, were not lysed by A and C. This inability to lyse persistently infected cells 
was not due to their enhanced membrane resistance or repair, since those cells 
were lysed efficiently by anti-H-2 antibodies and C. As judged by 50% cytotoxic- 
ity  end  point  determinations,  uninfected,  acutely infected,  and  persistently 
infected cells had similar levels of H-2 antigens on their surfaces. 
During previous studies of measles virus infection of HeLa cells, we showed 
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of infected cells (9),  making these cells resistant to both lymphocyte-mediated 
and  A-  and  C-dependent  lysis  (9,  11). In  those  studies,  the  amount  of viral 
antigens  expressed on the cell's surface correlated directly with the  ability of 
immune reagents to lyse the cell.  Lysis of measles virus-,  mumps virus-,  and 
herpes simplex virus-infected cells by specific anti-viral  A and C in a  homolo- 
gous system (human  cells,  A,  and  C)  (9,  10) required the binding of approxi- 
mately  5-7  x  108 A  molecules per  infected cell.  In the present  study,  which 
examined lysis of LCMV-infected cells with a heterologous system (mouse cells, 
guinea pig A, and C), 5-7  x  105 molecules of A had to bind per infected cell to 
specifically kill approximately 25-30% of acutely infected cells. In addition to the 
requirement  of A  to LCMV and C for immune lysis we noted that late in the 
acute infection C alone could lyse infected cells. This direct C lysis was not seen 
with uninfected or persistently infected cells and occurred only at a  restricted 
time period (days 3-7) during acute infection. This A-independent lysis was not 
associated  with  the  appearance  of C3  receptors  on  infected  cells.  Both  the 
mechanism  of direct  C activation  and the immunopathological  significance of 
this  observation  are  under  investigation.  The  direct  binding  to  and  lysis  or 
inactivation  of oncornaviruses  (49,  50),  Newcastle disease virus  (51,  52),  and 
tumors cells (53) by C in the absence of specific antibodies has been reported, 
and could possibly explain our results. 
In contrast to their insensitivity to A-dependent C-mediated lysis, most cells 
persistently  infected with LCMV were susceptible to immune  T-lymphocyte- 
mediated killing. Although 6% or less of these cells had detectable viral antigens 
on their  surfaces by immunofluorescence,  significant  numbers  were immuno- 
specifically killed by sensitized T lymphocytes (46% 51Cr released as compared to 
11%  control)  (Table  I).  In  all  eight  experiments  that  tested  the  ability  of 
sensitized T lymphocytes to kill LCMV acutely and persistently infected target 
cells,  we  noted  that  the  greatest  cell  death  occurred  2-4  days  after  acute 
infection and that lysis of persistently infected cells was never more than 66% of 
this  maximum  amount.  Those  persistently  infected  cells  which  escaped  T- 
lymphocyte killing were infected as judged by both the presence of cytoplasmic 
LCMV antigens and by the inability of any of these cells to be superinfected with 
LCMV. In other studies,  100% of the clones isolated from persistently infected 
cultures contained cells expressing viral antigens (29, 37). Hence, in persistently 
infected cultures, a significant percentage of infected cells (average, 40% of cells; 
range,  19-54%)  escaped lysis by sensitized  T  cells under  these conditions and 
nearly all such cells escaped killing by anti-LCMV A and C. 
There  appears  to  be two  major  explanations  why a  significant  number  of 
persistently infected cells were susceptible to T-lymphocyte-mediated lysis but 
not A-mediated C lysis. First, the T-lymphocyte cytotoxicity assay may be more 
sensitive than  the A  and  C  test.  Evidence from several systems support this 
view (54-56). A second explanation is that T lymphocytes may recognize differ- 
ent sets of antigens  or alterations  of antigens  (22) that  are not recognized by 
anti-viral antibodies. Although our data do not exclude either of these possibili- 
ties, the facts that (a) DI LCMV turned off S LCMV surface antigen expression 
and, in turn, the ability of sensitized T lymphocytes to kill virus-infected targets 
(Table VI) and that (b) Fab fragments of guinea pig IgG containing antibodies to 
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LCMV-infected targets  (inhibition  70-80%)  (M. B. A.  Oldstone and T. Tishon, 
unpublished  observations) favor the hypothesis that T  lymphocytes and  anti- 
viral antibodies recognize similar or related virus determinants but that the T 
lymphocytotoxicity assay is the more sensitive of the two. Others have shown 
that for T-lymphocyte killing of LCMV-infected murine targets to occur, both 
LCMV antigen and H-2 recognition is needed (22,  24). In our experiments,  the 
average concentration of H-2 antigens on surfaces of persistently infected cells 
approximated that on uninfected or acutely infected cells. 
Our  results  indicated  that  there  was  control  of viral  antigenic  expression 
during  the  LCMV infection  that  was  a  function  solely of virus  and  cell  and 
independent of the immune response.  Viral protein synthesis can be inhibited 
by interferon (57), but LCMV does not induce interferon synthesis in L-929 cells 
(31,  34,  35).  The relatively exclusive release of an interfering component from 
the persistently infected cells which had  little expression of cell surface viral 
antigens led us to explore the influence of this interfering component on viral 
antigen synthesis. Results published here and elsewhere (16, 32) clearly indicate 
that the interfering component released from persistently infected cells is a  DI 
virus:  (a) it interferes specifically with the synthesis of S LCMV but not with 
heterologous  viruses;  (b)  the  interference  is  not  cell  species  specific;  (c)  it 
sediments to a density slightly less than S LCMV; (g) it has the morphological 
characteristics of the LCM virion (P. Lampert, personal communication);  (e) it 
is inactivated by monospecific antisera to LCMV; (~ its UV inactivation kinet- 
ics suggest a small nucleic acid target size for interference;  (g) it is not synthe- 
sized unless cells are coinfected with S LCMV. Although no deletion in its RNA 
has yet been found, a deletion has been reported in the RNA of the DI virus of 
Pichinde  (58),  a  closely related virus. 
Similarly,  during  the  acute  LCMV infection  in  L-929  cells,  an  interfering 
component appears just before the shutdown in cell surface antigen synthesis. It 
has been shown and confirmed that this interfering  component resembles the 
purified DI virus in size, inactivation kinetics, and interference properties (31, 
59).  Whereas  S  LCMV  synthesis  peaked  at  days  2  and  3  postinfection,  the 
interfering component peaked on days 3 and 4. Antigenic expression on the cell 
surface was maximum on days 2-4 and then rapidly declined. Hence, there was 
as  association  between de  novo  synthesis of an  interfering  component  and  a 
reduction in surface antigen expression, as well as a precipitous reduction in the 
number  of cells  scoring  as  infective  centers.  The  fact  that  the  interfering 
component  when  transferred  to  susceptible  cells  blocked  S LCMV  infective 
center formation,  synthesis, and antigen production strongly suggests a  cause- 
effect role of the interfering component in the culture's ~turn-off." Others have 
suggested that a  difficult-to-see turbid plaque variant may also be responsible 
for interference during acute infection (60, 61). This seems unlikely as the turbid 
plaque variant should produce virus antigens which do not occur in this model. 
Further,  we have been unable to detect turbid plaques in this system, whereas 
we can detect turbid LCMV plaques on several cell lines with several strains of 
LCMV (31,  38). 
Administration  of DI LCMV to cells before or after S LCMV infection cur- 
tailed the production of viral antigens and could halt viral antigen synthesis at a 
time when antigens  were easily detected in the cytoplasm but not at the cell 1464  ANTIGENIC  REGULATION  BY  DEFECTIVE  INTERFERING  VIRUS 
surface. By pretreatment  with DI LCMV, cells infected with S LCMV could be 
rendered resistant to T-lymphocyte-mediated lysis, a very sensitive indicator of 
surface  antigen  expression.  DI  LCMV appeared  to block the  synthesis of all 
virion antigens, but whether under certain circumstances it could block prefer- 
entially the synthesis of surface but not cytoplasmic antigens is not known but 
currently is under investigation.  The observation that cells contained cytoplas- 
mic but not surface antigens might be explained by a generalized block in viral 
protein synthesis if there were a more rapid turnover rate of viral antigens on 
the cell surface than in the cytoplasm. Alternatively,  cells could be blocked in 
viral  antigen  synthesis  at  a  time  early  in  the  infection  when  cytoplasmic 
antigens  but  not  surface  antigens  were  present.  Support  for  a  generalized 
reduction in viral protein synthesis comes from current studies using polyacryl- 
amide gel analysis of 35S-methionine pulse-labeled viral proteins demonstrated 
in LCMV-infected cells. Using 30-min pulses, we noted that the synthesis of the 
60,000  dalton structural protein of LCMV (major protein) was undetectable in 
persistently infected cultures but was readily seen in acutely infected cultures. 
Superinfection of the persistently infected cultures with S LCMV did not result 
in detectable synthesis of this structural protein (M. Buchmeier, R. M. Welsh, 
and M. B. A. Oldstene, unpublished results). 
Whether or not DI virus plays a role in the establishment or maintenance  of 
the LCMV-carrier state in the mouse is unclear.  Peritoneal cells from persist- 
ently infected mice resemble persistently infected cells (which produce DI virus) 
in culture in that they have reduced expression of surface viral antigens and are 
resistant to superinfection with LCMV. Previously, Mims and Subrahmanyan 
(62) showed specific resistance  (homologous interference)  of peritoneal macro- 
phages from persistently infected mice to LCMV superinfection. They concluded 
that viral interference may play a role in the carrier state. Our studies confirm 
and extend their findings and point to the possibility that reduced expression of 
antigens on the cell's surface may render cells resistant to immunological attack 
in vivo. Recently we have presented evidence that in vivo synthesis of LCMV 
antigens in rats can be abrogated by experimental transfer of DI LCMV. 2 The 
fact that DI virus can be generated in vivo in experimental rabies (63), VSV (63), 
and reovirus (64) infections suggests that DI virus production may occur during 
natural  infection with LCMV.  LCMV-infected mice also have a  population of 
cells totally free of detectable antigens, though the virus is capable of infecting 
virtually every nucleated cell in the body. This may reflect DI virus-mediated 
interference,  as DI LCMV can block viral antigen  synthesis.  Data in Table X 
demonstrate  that  DI LCMV can interfere with S LCMV synthesis in primary 
cells taken from normal mice. 
Summary 
The expression of viral antigens on the surfaces of lymphocytic choriomenin- 
gitis virus (LCMV)-infected L-929 cells peaked 2-4 days postinfection and there- 
after precipitously declined.  Little  or no viral  antigen  was expressed on the 
2 Welsh, R.  M.,  P.  W.  Lampert, and M.  B.  A.  Oldstone.  1977. Prevention of virus-induced 
cerebellar disease by defective-interfering  lymphocytic choriomeningitis virus, d. Infect. Dis.  In 
press. RAYMOND  M.  WELSH  AND  MICHAEL  B.  A.  OLDSTONE  1465 
plasma membrane surfaces of persistently infected cells, but LCMV antigens 
were clearly present in the cytoplasms of most of those cells. Cells early after 
acute infection (days 2-4) were lysed by both virus-specific antibody and comple- 
ment (C) and immune T lymphocytes. To the contrary, antibody and C did not 
kill persistently infected cells, but T lymphocytes did kill such cells although at 
a lower efficiency  than acutely infected cells. The expression of  viral antigens on 
the surfaces of infected cells was regulated by the virus-cell interaction in the 
absence of immune reagents and was closely associated with defective interfer- 
ing (DI) LCMV interference. DI LCMV, per se, blocked the synthesis and cell 
surface expression of LCMV antigens, and DI LCMV generation immediately 
preceded a  precipitous reduction in cell surface antigenicity during the acute 
infection.  Persistently  infected  cells  produced  DI  LCMV  but  no  detectable 
S LCMV. Peritoneal cells isolated from mice persistently infected with LCMV 
resembled cultured persistently infected cells in their reduced expression of cell 
surface antigens  and their resistance to LCMV superinfection. It is proposed 
that DI virus-mediated interference with viral protein synthesis may allow cells 
to escape immune surveillance during persistent infections. 
The technical  and clerical  help of  Antoinette Tishon, Patty Tooker, Linda Eskra, Tania Justin, 
and Sally Hendrix is gratefully  acknowledged. 
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